Literature DB >> 2211994

Benign neonatal seizures.

D K Miles1, G L Holmes.   

Abstract

Benign neonatal seizures is a rare but increasingly recognized syndrome characterized by seizures in the neonatal or infantile period. Two forms are recognized: familial and nonfamilial. In both instances, the seizures may be quite severe, and status epilepticus is common. The nonfamilial form is characterized by idiopathic, self-limited seizures occurring in previously normal neonates. The seizures most commonly occur at day 5 and have been called "fifth-day fits" by some authors. Familial seizures most frequently have their onset during the first week of life, but onset may occur as late as early infancy. These seizures may recur for several months before resolving. No cause is found for the seizures, and the patient appears healthy during the interictal period. The family history reveals benign neonatal seizures in other family members. Although the prognosis is favorable in both syndromes, seizures may occasionally occur later in life in the familial form. The familial form of benign neonatal seizures is autosomal dominant, and the gene has been localized to chromosome 20.

Entities:  

Mesh:

Year:  1990        PMID: 2211994     DOI: 10.1097/00004691-199007000-00004

Source DB:  PubMed          Journal:  J Clin Neurophysiol        ISSN: 0736-0258            Impact factor:   2.177


  3 in total

1.  Genetic heterogeneity in benign familial neonatal convulsions: identification of a new locus on chromosome 8q.

Authors:  T B Lewis; R J Leach; K Ward; P O'Connell; S G Ryan
Journal:  Am J Hum Genet       Date:  1993-09       Impact factor: 11.025

2.  Benign infantile familial convulsions.

Authors:  F Vigevano; L Fusco; M Di Capua; S Ricci; R Sebastianelli; P Lucchini
Journal:  Eur J Pediatr       Date:  1992-08       Impact factor: 3.183

3.  KCNQ2 encephalopathy: delineation of the electroclinical phenotype and treatment response.

Authors:  Adam L Numis; Marco Angriman; Joseph E Sullivan; Ann J Lewis; Pasquale Striano; Rima Nabbout; Maria R Cilio
Journal:  Neurology       Date:  2013-12-26       Impact factor: 9.910

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.